Corrigendum: Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders.
Eduardo R Butelman, Mary Jeanne Kreek
Frontiers in Pharmacology 2015 correction DOI: 10.3389/fphar.2015.00285 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Correction notice |
|---|---|
| Topics | Addiction Depression Salvia divinorum |
| Keywords | Dynorphins Kappa-opioid receptor |
| Citations | 3 |
| Key points | The correction does not alter the review's scientific conclusions. |
Abstract
In the original review, we placed an incorrect citation in a sentence. The correct sentence and citation are as follows: "Also, salvinorin A can act as a “punisher” to self-administration of cocaine or a short-acting MOPr agonist in primates (when given contingently; Freeman et al., 2014).” The authors apologize for the mistake. This error does not change the scientific conclusions of the review. References (Please Add)Freeman, K.B., Naylor, J.E., Prisinzano, T.E., Woolverton, W.L. (2014) Assessment of the kappa opioid agonist, salvinorin A, as a punisher of drug self-administration in monkeys. Psychopharmacology (Berl) 231, 2751-2758. doi:10.1007/s00213-014-3436-2